デフォルト表紙
市場調査レポート
商品コード
1786795

動物用抗感染症薬市場、規模、シェア、動向、産業分析レポート:動物タイプ別、薬剤クラス別、投与経路別、エンドユーザー別、地域別-2025~2034年市場予測

Veterinary Anti-infectives Market Size, Share, Trends, & Industry Analysis Report By Animal Type (Livestock and Companion), By Drug Class, By Route of Administration, By End User, and By Region - Market Forecast, 2025-2034


出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
動物用抗感染症薬市場、規模、シェア、動向、産業分析レポート:動物タイプ別、薬剤クラス別、投与経路別、エンドユーザー別、地域別-2025~2034年市場予測
出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、動物用抗感染症薬の市場規模は2034年までに157億1,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

動物用抗感染症薬市場は、畜産業者やペットの飼い主が動物の感染症を管理するために信頼できる治療法を求めているため、世界的に強い需要が見られます。動物の健康、食の安全、病気の予防に対する意識の高まりが、抗生物質、抗ウイルス剤、抗真菌剤、抗寄生虫製品の使用を、家畜とコンパニオンアニマルの両方で促進しています。

同市場の企業は、治療成績と利便性を向上させるため、製品ラインナップを拡大し、新しいドラッグデリバリーシステムに投資しています。動物用診断法の進歩や新興地域における動物医療インフラの成長が市場の成長を支え、効果的な動物用ヘルスケアソリューションへのアクセスを増やしています。

動物用抗感染症薬市場レポートハイライト

動物タイプ別では、牛、家禽、豚で細菌、ウイルス、寄生虫感染が広く蔓延していることから、2024年には家畜セグメントが市場を独占しました。

薬剤クラス別では、抗菌剤セグメントが2024年の市場を独占しました。これは、動物タイプを問わず広範な動物の疾病を治療するための広域スペクトルソリューションの採用が増加しているためです。

投与経路別では、経口セグメントが2024年に市場を独占しました。これは、家畜生産における投与の容易さによるもので、薬用飼料や水システムが効率的な大量治療を可能にします。

エンドユーザー別では、先進的診断ツール、熟練した獣医専門家、整備された治療インフラが利用できることから、動物病院セグメントが2024年に最大の市場シェアを占めました。

北米は、ペットの飼育率が高く、米国とカナダではコンパニオンアニマルのケアに対する需要が旺盛であることから、2024年の世界の動物用抗感染症薬市場で大半のシェアを占めました。

アジア太平洋は、動物ヘルスケアのインフラが改善され、食の安全と家畜の生産性が重視されるようになったことから、予測期間中に大きく成長すると予想されます。

世界の主要市場参入企業には、Biogenesis Bago S.A.、Boehringer Ingelheim GmbH、Calier S.A.、Ceva Sante Animale S.A.、Dechra Pharmaceuticals Plc.、Elanco Animal Health Incorporated、Intervet International B.V.(Merckの子会社)、Merck & Co., Inc.、Norbrook Laboratories Ltd.、Phibro Animal Health Corporation、Vetoquinol S.A.、Virbac S.A.、Zoetis Inc.、Bayer AG、Bimeda Animal Health Limitedがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の動物用抗感染症薬市場洞察

  • 市場スナップショット
  • 動物用抗感染症薬市場力学
    • 促進要因と機会
      • 動物における人獣共通感染症と感染症の急増
      • 成長する獣医ヘルスケアインフラ
    • 抑制要因と課題
      • 発展途上地域における価格感応性
  • PESTEL分析
  • 動物用抗感染症薬市場の動向
  • バリューチェーン分析

第5章 世界の動物用抗感染症薬市場:動物タイプ別

  • 主要調査結果
  • イントロダクション
  • 家畜
  • コンパニオンアニマル

第6章 世界の動物用抗感染症薬市場:薬剤クラス別

  • 主要調査結果
  • イントロダクション
  • 抗菌剤
  • 抗ウイルス剤
  • 抗真菌剤
  • 抗寄生虫剤

第7章 世界の動物用抗感染症薬市場:投与経路別

  • 主要調査結果
  • イントロダクション
  • 経口
  • 非経口
  • 局所

第8章 世界の動物用抗感染症薬市場:エンドユーザー別

  • 主要調査結果
  • イントロダクション
  • 動物病院
  • 動物クリニック
  • その他

第9章 世界の動物用抗感染症薬市場:地域

  • 主要調査結果
  • イントロダクション
    • 動物用抗感染症薬市場評価:地域、2020~2034年
  • 北米
    • 北米:動物タイプ別、2020~2034年
    • 北米:薬剤クラス別、2020~2034年
    • 北米:投与経路別、2020~2034年
    • 北米:エンドユーザー別、2020~2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州:動物タイプ別、2020~2034年
    • 欧州:薬剤クラス別、2020~2034年
    • 欧州:投与経路別、2020~2034年
    • 欧州:エンドユーザー別、2020~2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他の欧州
  • アジア太平洋
    • アジア太平洋:動物タイプ別、2020~2034年
    • アジア太平洋:薬剤クラス別、2020~2034年
    • アジア太平洋:投与経路別、2020~2034年
    • アジア太平洋:エンドユーザー別、2020~2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ:動物タイプ別、2020~2034年
    • 中東・アフリカ:薬剤クラス別、2020~2034年
    • 中東・アフリカ:投与経路別、2020~2034年
    • 中東・アフリカ:エンドユーザー別、2020~2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ:動物タイプ別、2020~2034年
    • ラテンアメリカ:薬剤クラス別、2020~2034年
    • ラテンアメリカ:投与経路別、2020~2034年
    • ラテンアメリカ:エンドユーザー別、2020~2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他のラテンアメリカ

第10章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Biogenesis Bago S.A.
  • Boehringer Ingelheim GmbH
  • Calier S.A.
  • Ceva Sante Animale S.A.
  • Dechra Pharmaceuticals Plc.
  • Elanco Animal Health Incorporated
  • Intervet International B.V.
  • Merck & Co., Inc.
  • Norbrook Laboratories Ltd.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Virbac S.A.
図表

List of Tables:

  • Table 1 Global Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 2 Global Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 3 Global Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 4 Global Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 5 North America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 6 North America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 7 North America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 8 North America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 9 U.S.: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 10 U.S.: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 11 U.S.: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 12 U.S.: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Canada: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 14 Canada: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 15 Canada: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 16 Canada: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 17 Europe: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 18 Europe: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 19 Europe: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 20 Europe: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 21 UK: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 22 UK: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 23 UK: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 24 UK: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 25 France: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 26 France: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 27 France: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 28 France: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 29 Germany: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 30 Germany: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 31 Germany: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 32 Germany: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 33 Italy: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 34 Italy: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 35 Italy: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 36 Italy: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Spain: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 38 Spain: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 39 Spain: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 40 Spain: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 45 Russia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 46 Russia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 47 Russia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 48 Russia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 57 China: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 58 China: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 59 China: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 60 China: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 61 India: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 62 India: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 63 India: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 64 India: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 69 Japan: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 70 Japan: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 71 Japan: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 72 Japan: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 77 South Korea: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 78 South Korea: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 79 South Korea: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 80 South Korea: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 81 Australia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 82 Australia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 83 Australia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 84 Australia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 97 UAE: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 98 UAE: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 99 UAE: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 100 UAE: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 101 Israel: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 102 Israel: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 103 Israel: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 104 Israel: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 105 South Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 106 South Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 107 South Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 108 South Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 113 Latin America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 114 Latin America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 115 Latin America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 116 Latin America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 117 Mexico: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 118 Mexico: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 119 Mexico: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 120 Mexico: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 121 Brazil: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 122 Brazil: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 123 Brazil: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 124 Brazil: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 125 Argentina: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 126 Argentina: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 127 Argentina: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 128 Argentina: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Veterinary Anti-infectives Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Animal Type
  • Figure 7. Global Veterinary Anti-infectives Market, by Animal Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Drug Class
  • Figure 9. Global Veterinary Anti-infectives Market, by Drug Class, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Veterinary Anti-infectives Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End User
  • Figure 13. Global Veterinary Anti-infectives Market, by End User, 2024 & 2034 (USD Billion)
目次
Product Code: PM6056

The veterinary anti-infectives market size is expected to reach USD 15.71 Billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Anti-infectives Market Size, Share, Trends, & Industry Analysis Report By Animal Type (Livestock and Companion), By Drug Class, By Route of Administration, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The veterinary anti-infectives market is witnessing strong global demand as livestock producers and pet owners seek reliable treatments to manage animal infections. Rising awareness about animal health, food safety, and disease prevention is driving the use of antibiotics, antivirals, antifungals, and antiparasitic products across both farm and companion animals.

Companies in the market are expanding product offerings and investing in new drug delivery systems to improve treatment outcomes and convenience. Advancements in veterinary diagnostics and growing veterinary care infrastructure in emerging regions, are supporting market growth and increasing access to effective animal healthcare solutions.

Veterinary Anti-infectives Market Report Highlights

Based on animal type, the livestock segment dominated the market in 2024, due to the widespread prevalence of bacterial, viral, and parasitic infections in cattle, poultry, and swine.

In terms of drug class, the antimicrobial segment dominated the market in 2024. This is owing to the rising adoption of broad-spectrum solutions for treating a wide range of animal diseases across species.

Based on route of administration, the oral segment dominated the market in 2024, due to ease of administration in livestock production, where medicated feed and water systems allow efficient mass treatment.

Based on end user, the veterinary hospitals segment held largest market share in 2024, owing to the availability of advanced diagnostic tools, skilled veterinary professionals, and well-developed treatment infrastructure.

North America accounted for the majority share in the global veterinary anti-infectives market in 2024, attributed to high pet ownership rates and strong demand for companion animal care in the U.S. and Canada.

Asia Pacific is expected to grow significantly during the forecast period, owing to improving animal healthcare infrastructure and rising emphasis on food safety and livestock productivity.

A few global key market players include Biogenesis Bago S.A., Boehringer Ingelheim GmbH, Calier S.A., Ceva Sante Animale S.A., Dechra Pharmaceuticals Plc., Elanco Animal Health Incorporated, Intervet International B.V. (a subsidiary of Merck & Co., Inc.), Merck & Co., Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corporation, Vetoquinol S.A., Virbac S.A., Zoetis Inc., Bayer AG, Bimeda Animal Health Limited.

Polaris Market Research has segmented the market report on the basis of animal type, drug class, route of administration, end user vertical, and region:

By Animal Type Outlook (Revenue, USD Billion, 2020-2034)

Livestock

Companion

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

Antimicrobial Agents

Antiviral Agents

Antifungal Agents

Antiparasitic Agents

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Oral

Parenteral

Topical

By End User Vertical Outlook (Revenue, USD Billion, 2020-2034)

Veterinary Hospitals

Veterinary Clinics

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Veterinary Anti-infectives Market Insights

  • 4.1. Veterinary Anti-infectives Market - Market Snapshot
  • 4.2. Veterinary Anti-infectives Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Surge in Zoonotic and Infectious Diseases in Animals
      • 4.2.1.2. Growing Veterinary Healthcare Infrastructure
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Price Sensitivity in Developing Regions
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Anti-infectives Market Trends
  • 4.6. Value Chain Analysis

5. Global Veterinary Anti-infectives Market, by Animal Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
  • 5.3. Livestock
    • 5.3.1. Global Veterinary Anti-infectives Market, by Livestock, by Region, 2020-2034 (USD Billion)
  • 5.4. Companion
      • 5.4.1.1. Global Veterinary Anti-infectives Market, by Companion, by Region, 2020-2034 (USD Billion)

6. Global Veterinary Anti-infectives Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
  • 6.3. Antimicrobial Agents
    • 6.3.1. Global Veterinary Anti-infectives Market, by Antimicrobial Agents, by Region, 2020-2034 (USD Billion)
  • 6.4. Antiviral Agents
    • 6.4.1. Global Veterinary Anti-infectives Market, by Antiviral Agents, by Region, 2020-2034 (USD Billion)
  • 6.5. Antifungal Agents
    • 6.5.1. Global Veterinary Anti-infectives Market, by Antifungal Agents, by Region, 2020-2034 (USD Billion)
  • 6.6. Antiparasitic Agents
    • 6.6.1. Global Veterinary Anti-infectives Market, by Antiparasitic Agents, by Region, 2020-2034 (USD Billion)

7. Global Veterinary Anti-infectives Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Oral
    • 7.3.1. Global Veterinary Anti-infectives Market, by Oral, by Region, 2020-2034 (USD Billion)
  • 7.4. Parenteral
    • 7.4.1. Global Veterinary Anti-infectives Market, by Parenteral, by Region, 2020-2034 (USD Billion)
  • 7.5. Topical
    • 7.5.1. Global Veterinary Anti-infectives Market, by Topical, by Region, 2020-2034 (USD Billion)

8. Global Veterinary Anti-infectives Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • 8.3. Veterinary Hospitals
    • 8.3.1. Global Veterinary Anti-infectives Market, by Veterinary Hospitals, by Region, 2020-2034 (USD Billion)
  • 8.4. Veterinary Clinics
    • 8.4.1. Global Veterinary Anti-infectives Market, by Veterinary Clinics, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Veterinary Anti-infectives Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Veterinary Anti-infectives Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Veterinary Anti-infectives Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Veterinary Anti-infectives Market - North America
    • 9.3.1. North America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
    • 9.3.3. North America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.4. North America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.3.5. Veterinary Anti-infectives Market - U.S.
      • 9.3.5.1. U.S.: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.3.6. Veterinary Anti-infectives Market - Canada
      • 9.3.6.1. Canada: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • 9.4. Veterinary Anti-infectives Market - Europe
    • 9.4.1. Europe: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.4.5. Veterinary Anti-infectives Market - UK
      • 9.4.5.1. UK: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.4.6. Veterinary Anti-infectives Market - France
      • 9.4.6.1. France: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.4.7. Veterinary Anti-infectives Market - Germany
      • 9.4.7.1. Germany: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.4.8. Veterinary Anti-infectives Market - Italy
      • 9.4.8.1. Italy: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.4.9. Veterinary Anti-infectives Market - Spain
      • 9.4.9.1. Spain: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.4.10. Veterinary Anti-infectives Market - Netherlands
      • 9.4.10.1. Netherlands: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.4.11. Veterinary Anti-infectives Market - Russia
      • 9.4.11.1. Russia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.4.12. Veterinary Anti-infectives Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • 9.5. Veterinary Anti-infectives Market - Asia Pacific
    • 9.5.1. Asia Pacific: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.5.5. Veterinary Anti-infectives Market - China
      • 9.5.5.1. China: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.5.6. Veterinary Anti-infectives Market - India
      • 9.5.6.1. India: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.5.7. Veterinary Anti-infectives Market - Malaysia
      • 9.5.7.1. Malaysia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.5.8. Veterinary Anti-infectives Market - Japan
      • 9.5.8.1. Japan: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.5.9. Veterinary Anti-infectives Market - Indonesia
      • 9.5.9.1. Indonesia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.5.10. Veterinary Anti-infectives Market - South Korea
      • 9.5.10.1. South Korea: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.5.11. Veterinary Anti-infectives Market - Australia
      • 9.5.11.1. Australia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.5.12. Veterinary Anti-infectives Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • 9.6. Veterinary Anti-infectives Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.6.5. Veterinary Anti-infectives Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.6.6. Veterinary Anti-infectives Market - UAE
      • 9.6.6.1. UAE: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.6.7. Veterinary Anti-infectives Market - Israel
      • 9.6.7.1. Israel: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.6.8. Veterinary Anti-infectives Market - South Africa
      • 9.6.8.1. South Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.6.9. Veterinary Anti-infectives Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
  • 9.7. Veterinary Anti-infectives Market - Latin America
    • 9.7.1. Latin America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.7.5. Veterinary Anti-infectives Market - Mexico
      • 9.7.5.1. Mexico: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.7.6. Veterinary Anti-infectives Market - Brazil
      • 9.7.6.1. Brazil: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.7.7. Veterinary Anti-infectives Market - Argentina
      • 9.7.7.1. Argentina: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)
    • 9.7.8. Veterinary Anti-infectives Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Veterinary Anti-infectives Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Veterinary Anti-infectives Market, by Drug Class, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Veterinary Anti-infectives Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Veterinary Anti-infectives Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Biogenesis Bago S.A.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Boehringer Ingelheim GmbH
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Calier S.A.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Ceva Sante Animale S.A.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Dechra Pharmaceuticals Plc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Elanco Animal Health Incorporated
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Intervet International B.V.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Merck & Co., Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Norbrook Laboratories Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Phibro Animal Health Corporation
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Vetoquinol S.A.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Virbac S.A.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development